Tag: 1 MannKind Corporation

Browse exclusive Tags!

MannKind Sells 1% Tyvaso DPI Royalty for $200M, US

MannKind sells 1% Tyvaso DPI royalty to Sagard Healthcare for $200M, providing a financial boost and new growth opportunities. This significant deal propels MannKind's position in the pharmaceutical industry.

Popular

Subscribe

spot_imgspot_img